Drawing for A FRONT DOOR TO HEALTH CARE

USPTO serial 88184902

A FRONT DOOR TO HEALTH CARE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SALCIDO, JOHN CHARLES
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with A FRONT DOOR TO HEALTH CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Erich G. Rhynhart

Erich G. Rhynhart CVS PHARMACY, INC.ONE CVS DRIVEMAIL CODE: 1160WOONSOCKET, RI 02895

Goods and services

ClassDescriptionStatusFirst use
035Health care utilization and review services as they relate to prescription drugs, namely, pharmaceutical cost management and drug review utilization services, verification of benefits, prior authorization and review services and coordination of delivery and access to prescription drugs; retail store and online retail pharmacy services in the field of prescription drugs, healthcare, general merchandise and beauty products; mail order of pharmaceuticals and specialty pharmaceuticals and specialty pharmaceuticals distributorship services; procurement, namely, purchasing pharmaceuticals for othersACTIVE—
036Claims processing of pharmaceutical insurance benefits, namely, processing and administering individual prescription claims history, benefit amounts, accumulations for deductibles and out-of-pocket expenses and expense summaries; underwriting insurance for pre-paid healthcare; insurance and financial services pertaining to submission of medical claims, and handling of assignment of benefits, namely, medical insurance claims administrative services, administration of medical and pharmaceutical reimbursement collection programs, administration of employee pharmaceutical benefits, administration of prepaid employee health care plans, financial counseling, and payment for medical services involving home and hospital care; pharmacy benefit management services; organizing and administering preferred provider plans for a network of pharmacy providers; health insurance services, namely, underwriting, issuance and administration of health insurance; health insurance services, namely, insurance claims administrationACTIVE—
044Providing medical information regarding prescription drugs and drug therapy; providing information regarding patients' prescription drugs and drug therapy; developing and managing comprehensive programs comprising drug therapy and physician support services in the nature of providing consultation in the dispensing of pharmaceuticals for persons with chronic health issues; medical services, namely, providing therapy management services relating to the provision of in-home and ambulatory infusion therapies and nutritional therapy services; medical services, namely, infusion services provided at home and in clinics; nursing services; providing medical information concerning hemophilia; providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals and nutritional therapy services; providing consultation in the dispensing of pharmaceuticals and pharmaceutical advice; medical clinic featuring non-emergency medical diagnostic services in convenient locationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 5, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 4, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 4, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2021EX5GSOU EXTENSION 5 GRANTED—
Nov 3, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Oct 27, 2021EXT5SOU EXTENSION 5 FILED—
Oct 27, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 29, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 27, 2021EX4GSOU EXTENSION 4 GRANTED—
Apr 27, 2021EXT4SOU EXTENSION 4 FILED—
Apr 27, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 5, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 3, 2020EX3GSOU EXTENSION 3 GRANTED—
Nov 3, 2020EXT3SOU EXTENSION 3 FILED—
Nov 3, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 19, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 15, 2020EX2GSOU EXTENSION 2 GRANTED—
May 15, 2020EXT2SOU EXTENSION 2 FILED—
May 15, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 28, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 26, 2019EX1GSOU EXTENSION 1 GRANTED—
Nov 26, 2019EXT1SOU EXTENSION 1 FILED—
Nov 26, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 28, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 2, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 2, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 15, 2019ALIEASSIGNED TO LIE—
Feb 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Feb 4, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 4, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 4, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 31, 2019DOCKASSIGNED TO EXAMINER—
Nov 24, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 10, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance